1. Home
  2. CMPS vs TG Comparison

CMPS vs TG Comparison

Compare CMPS & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • TG
  • Stock Information
  • Founded
  • CMPS 2020
  • TG 1988
  • Country
  • CMPS United Kingdom
  • TG United States
  • Employees
  • CMPS N/A
  • TG N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • TG Metal Fabrications
  • Sector
  • CMPS Health Care
  • TG Industrials
  • Exchange
  • CMPS Nasdaq
  • TG Nasdaq
  • Market Cap
  • CMPS 364.9M
  • TG 301.0M
  • IPO Year
  • CMPS 2020
  • TG 1989
  • Fundamental
  • Price
  • CMPS $2.74
  • TG $8.76
  • Analyst Decision
  • CMPS Strong Buy
  • TG
  • Analyst Count
  • CMPS 7
  • TG 0
  • Target Price
  • CMPS $17.83
  • TG N/A
  • AVG Volume (30 Days)
  • CMPS 3.9M
  • TG 65.3K
  • Earning Date
  • CMPS 07-31-2025
  • TG 08-06-2025
  • Dividend Yield
  • CMPS N/A
  • TG N/A
  • EPS Growth
  • CMPS N/A
  • TG N/A
  • EPS
  • CMPS N/A
  • TG N/A
  • Revenue
  • CMPS N/A
  • TG $617,839,000.00
  • Revenue This Year
  • CMPS N/A
  • TG N/A
  • Revenue Next Year
  • CMPS N/A
  • TG N/A
  • P/E Ratio
  • CMPS N/A
  • TG N/A
  • Revenue Growth
  • CMPS N/A
  • TG 17.42
  • 52 Week Low
  • CMPS $2.25
  • TG $4.31
  • 52 Week High
  • CMPS $8.54
  • TG $9.22
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 29.61
  • TG 59.27
  • Support Level
  • CMPS $2.25
  • TG $8.45
  • Resistance Level
  • CMPS $5.15
  • TG $8.90
  • Average True Range (ATR)
  • CMPS 0.40
  • TG 0.22
  • MACD
  • CMPS -0.27
  • TG -0.01
  • Stochastic Oscillator
  • CMPS 9.83
  • TG 78.89

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

Share on Social Networks: